We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Nanoparticles Deliver Viral Gene That Activates Toxic Drug Inside Brain Cancer Cells

By LabMedica International staff writers
Posted on 17 Feb 2015
Print article
Image: Nanoparticles in low and high resolution micrographs (Photo courtesy of Green Laboratory, Johns Hopkins University).
Image: Nanoparticles in low and high resolution micrographs (Photo courtesy of Green Laboratory, Johns Hopkins University).
Cancer researchers have described a nanoparticle-based gene therapy system that inserted the gene for the enzyme herpes simplex virus type I thymidine kinase (HSVtk) into brain tumor (glioma) cells and rendered them highly sensitive to the chemotherapeutic agent ganciclovir.

Ganciclovir is a synthetic analogue of 2′-deoxy-guanosine. It is first phosphorylated to ganciclovir monophosphate by a viral kinase during infection. Subsequently, cellular kinases catalyze the formation of ganciclovir diphosphate and ganciclovir triphosphate, which is present in 10-fold greater concentrations in Cytomegalovirus (CMV) or herpes simplex virus (HSV)-infected cells than uninfected cells. Ganciclovir triphosphate is a competitive inhibitor of deoxyguanosine triphosphate (dGTP) incorporation into DNA and preferentially inhibits viral DNA polymerases more than cellular DNA polymerases. In addition, ganciclovir triphosphate serves as a poor substrate for chain elongation, thereby disrupting viral DNA synthesis by a second route. Use of ganciclovir for cancer treatment is restricted by a range of serious side effects. Common adverse drug reactions include: granulocytopenia, neutropenia, anemia, thrombocytopenia, fever, nausea, vomiting, dyspepsia, diarrhea, abdominal pain, raised liver enzymes, headache, confusion, hallucination, seizures, pain and phlebitis at injection site (due to high pH), sweating, rash, itch, increased serum creatinine and blood urea concentrations. Furthermore, ganciclovir is considered a potential human carcinogen, teratogen, and mutagen.

Investigators at Johns Hopkins University (Baltimore, MD, USA) devised a way to use a less toxic pro-drug form of ganciclovir (GCV) that would become activated by HSVtk enzyme action localized inside the cancer cells. To transport the HSVtk gene to tumor cells they fabricated nanoparticles from HSVtk DNA combined with the poly(beta-amino ester) (PBAE) polymer, poly(1,4-butanediol diacrylate-co-4-amino-1-butanol) end-modified with 1-(3-aminopropyl)-4-methylpiperazine. The nanoparticles were 138 ± 4 nanometers in size and 13 ± 1 millivolts in zeta potential.

Results published in the February 2, 2015, online edition of the journal ACS Nano revealed that the HSVtk DNA-containing nanoparticles showed 100% cancer cell killing in vitro in two glioma cell lines when combined with GCV exposure, while control nanoparticles encoding an irrelevant gene maintained robust cell viability.

For in vivo evaluation, tumor-bearing rats were treated with PBAE/HSVtk infusion via convection-enhanced delivery (CED) in combination with systemic administration of GCV. Intracranial CED employed a pressure gradient to enhance diffusion throughout the tumor. Following a single CED infusion, labeled PBAE nanoparticles spread completely throughout the tumor, and the treated animals showed a significant benefit in survival.

"We evaluated the system in rats with glioma and found that by using a method called intracranial convection-enhanced delivery, our nanoparticles could penetrate completely throughout the tumor following a single injection," said senior author Dr. Jordan J. Green, associate professor of biomedical engineering and ophthalmology at Johns Hopkins University. "When combined with systemic administration of ganciclovir, rats with malignant glioma lived significantly longer than rats that did not receive this treatment. We will move forward by evaluating this technology in additional brain cancer animal models."

Related Links:

Johns Hopkins University


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Automated Blood Typing System
IH-500 NEXT
New
Centrifuge
Centrifuge 5430/ 5430 R
New
Hepatitis B Virus Test
HBs Ab – ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.